GSA CAPITAL PARTNERS LLP - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 89 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q2 2020$359,000
+23.4%
3,511
+40.4%
0.20%
+488.2%
Q4 2019$291,000
+1.7%
2,5000.0%0.03%
-12.8%
Q3 2019$286,000
-81.9%
2,500
-84.3%
0.04%
-50.0%
Q2 2018$1,579,000
-32.6%
15,900
-45.0%
0.08%
-37.1%
Q1 2018$2,342,000
+5.4%
28,910
+2.5%
0.12%
-8.1%
Q4 2017$2,221,000
+86.3%
28,200
+118.4%
0.14%
+66.7%
Q3 2017$1,192,00012,9150.08%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2018
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders